tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

LDOS · Q2 2025 Earnings

Leidos

Reported August 5, 2025

30-second summary

Revenue grew 3% YoY to $4.25B with non-GAAP EPS of $3.21 and adjusted EBITDA margin of 15.2%, but the print is not the story — management raised FY25 revenue, EPS midpoint (+$0.75 to $11.30), EBITDA margin (mid-to-high 12s → mid 13s), and operating cash flow ($1.45B → $1.65B) guidance simultaneously. The tone shift from May's "severely constrained procurement" to August's "logjam is breaking up" is the headline, and management is backing it by reinstating "tens of millions" of indirect investment they had been holding back. Book-to-bill of 0.9 in the quarter is the one soft spot; pro-forma 1.3 including a multibillion-dollar IC takeaway that definitized in early Q3, plus the $70B pipeline and $9-13B in near-term addressable funding identified by management across FAA modernization, autonomous shipbuilding, border/inspection, and counter-UAS, supports the back-half acceleration thesis.

Headline numbers

EPS

Q2 FY2025

$3.21

Revenue

Q2 FY2025

$4.25B

+3.0% YoY

Gross margin

Q2 FY2025

18.5%

Free cash flow

Q2 FY2025

$0.46B

Operating margin

Q2 FY2025

13.4%

Key financials

Q2 FY2025
MetricQ2 FY2025YoY
Revenue$4.25B+3.0%
EPS$3.21—
Gross margin18.5%—
Operating margin13.4%—
Free cash flow$0.46B—

Guidance

Prior quarter data unavailable — comparison not possible.

Segment KPIs

Q2 FY2025
SegmentQ2 FY2025YoY
National Security & Digital$1.872B+3.3%
Health & Civil$1.272B+0.7%
Commercial & International$0.566B+0.9%
Defense Systems$0.543B+9.7%

Other KPIs

Q2 FY2025
SegmentQ2 FY2025
Adjusted EBITDA$647M
Adjusted EBITDA Margin15.2%
Total Backlog$46.2B
Funded Backlog$7.1B
Book-to-Bill Ratio0.9
Net Bookings$3.9B
Operating Cash Flow Conversion124%
Free Cash Flow Conversion110%

Management tone

Management is in a markedly more offensive posture than the May call. The cumulative tone shift is from defensive navigation of DOGE/administration disruption to active alignment with the efficiency agenda as a tailwind. Four specific shifts stand out.

From "procurement is severely constrained" to "the logjam is breaking up." In May, management framed the first several months of the administration as a procurement freeze. In August: "awards are picking up and the administration is clearly moving forward" and "we expect much greater awards pace in the back half of this year." The 0.9 in-quarter book-to-bill against a 1.3 pro-forma figure tells you the freeze was real; the forward language tells you they have visibility into the thaw.

From DOGE-as-threat to DOGE-as-flattening. The disruption curve language has changed: "while there was a reasonably high slope in that curve during the first half of those six months, here in the last three months, that's been flat." Management now characterizes the conversation with cabinet secretaries as constructive — "the government is now transitioning from policy to productivity" — positioning Leidos as the solution provider rather than the target.

From austerity to reinvestment. In May management touted "tight controls on indirect expenses." In August: "it's time to go back to more normal operations for most of that" with "tens of millions of dollars of incremental investment" planned for H2. This is a concrete capital allocation signal, not a sentiment shift — and it is paired with continued share repurchases and debt paydown.

From organic-only to integrated organic + M&A. The KUDU acquisition is being credited with "$400 million in pipeline opportunities that neither company was pursuing separately." Maritime autonomy (LAVA) is sized by management as a "nearly $4 billion pipeline for Leidos over the coming years," distinct from the $2-3B autonomous shipbuilding bucket within the OBBB addressable spend walk. Combined with the broader $9-13B One Big Beautiful Bill opportunity set, the growth algorithm has shifted from defending share to compounding through portfolio integration.

The risk language remains — "we believe it's prudent to account for some potential customer delays and other unknowns" — but it now coexists with raised guidance across every metric. That is a confident posture wrapped in deliberate range discipline, not hedging.

Recurring themes management leaned on this quarter:

Administration efficiency agenda alignment and trusted mission AI as core competitive moatOne Big Beautiful Bill funding unlocking $12-15B in addressable opportunities across all growth pillarsMaritime autonomy and Golden Dome as near-term revenue and margin acceleratorsOperational flexibility: austerity-to-investment pivot demonstrating business model agilityKUDU acquisition synergies and Dynetics maturation driving portfolio momentumBook-to-bill recovery (1.3 trailing 12-month) and $70B pipeline with 75% takeaway work

Risks management surfaced:

Revenue reductions from customer reviews and potential delays (prudently embedded in narrowed guidance range)Large competitive IDIQ award ($10B) in DOD consolidation space, though positioned as opportunity not threatOngoing DOGE-related procurement reviews and cost-efficiency mandates, though trajectory flatteningFourth medical exam vendor staffing and competitive dynamics in health segment (estimated <1% share impact to date)Incremental funding dynamics in certain customer environments replacing multi-year commitments

What to watch into next quarter

Book-to-bill recovery in Q3. In-quarter book-to-bill of 0.9 is the weakest data point in the release. Watch whether Q3 prints above 1.0 as the "logjam breaking up" narrative requires; the pro-forma 1.3 (which would have printed had the IC takeaway definitized in June) is the bar to defend.

Funded backlog conversion. Funded backlog of $7.1B versus $46.2B total is the gating metric for revenue acceleration. Watch whether funded backlog grows sequentially and what % of the $70B pipeline converts to awards in H2.

One Big Beautiful Bill capture rate. Management sized the near-term addressable opportunity at $9-13B across FAA, autonomous shipbuilding, border/inspection, and counter-UAS. Watch for specific awards or task orders attributed to OBBB funding in Q3 — without concrete wins by year-end, the addressable framing becomes promotional.

Health & Civil stabilization. +0.7% YoY is the segment to watch given the fourth medical exam vendor entering. Watch whether H&C growth accelerates or decelerates from here; sustained sub-1% growth would call the FY guide into question.

Indirect investment discipline. Management is reinstating "tens of millions" in indirect spend in H2. Watch whether adjusted EBITDA margin holds the mid-13s guide despite the investment ramp — any margin compression below 13% would signal the pivot was premature.

Sources

  1. Leidos Q2 2025 Press Release — https://www.sec.gov/Archives/edgar/data/1336920/000133692025000031/ldos070425q2pressreleaseex.htm

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.